These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 33356742)

  • 1. Chitosan caged liposomes for improving oral bioavailability of rivaroxaban:
    Elsayad MK; Mowafy HA; Zaky AA; Samy AM
    Pharm Dev Technol; 2021 Mar; 26(3):316-327. PubMed ID: 33356742
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacokinetic and pharmacodynamic evaluation of oral rivaroxaban in healthy adult cats.
    Dixon-Jimenez AC; Brainard BM; Brooks MB; Nie B; Arnold RD; Loper D; Abrams JC; Rapoport GS
    J Vet Emerg Crit Care (San Antonio); 2016 Sep; 26(5):619-29. PubMed ID: 27599304
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Assessment of Dose Proportionality of Rivaroxaban Nanocrystals.
    Demir H; Gulsun T; Ozkan MH; Nemutlu E; Sahin S; Öner L
    AAPS PharmSciTech; 2020 Aug; 21(6):228. PubMed ID: 32767034
    [TBL] [Abstract][Full Text] [Related]  

  • 4. N-trimethyl chitosan chloride-coated liposomes for the oral delivery of curcumin.
    Chen H; Wu J; Sun M; Guo C; Yu A; Cao F; Zhao L; Tan Q; Zhai G
    J Liposome Res; 2012 Jun; 22(2):100-9. PubMed ID: 22007962
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Chitosan-Coated Flexible Liposomes Magnify the Anticancer Activity and Bioavailability of Docetaxel: Impact on Composition.
    Alshraim MO; Sangi S; Harisa GI; Alomrani AH; Yusuf O; Badran MM
    Molecules; 2019 Jan; 24(2):. PubMed ID: 30641899
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Formulation of Piperine-Chitosan-Coated Liposomes: Characterization and In Vitro Cytotoxic Evaluation.
    Imam SS; Alshehri S; Altamimi MA; Hussain A; Qamar W; Gilani SJ; Zafar A; Alruwaili NK; Alanazi S; Almutairy BK
    Molecules; 2021 May; 26(11):. PubMed ID: 34072306
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chitosan-modified cholesterol-free liposomes for improving the oral bioavailability of progesterone.
    Wang M; Liu M; Xie T; Zhang BF; Gao XL
    Colloids Surf B Biointerfaces; 2017 Nov; 159():580-585. PubMed ID: 28854414
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Preparation and Optimization of Rivaroxaban by Self-Nanoemulsifying Drug Delivery System (SNEDDS) for Enhanced Oral Bioavailability and No Food Effect.
    Xue X; Cao M; Ren L; Qian Y; Chen G
    AAPS PharmSciTech; 2018 May; 19(4):1847-1859. PubMed ID: 29637496
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Possible role of rivaroxaban in attenuating pressure-overload-induced atrial fibrosis and fibrillation.
    Kondo H; Abe I; Fukui A; Saito S; Miyoshi M; Aoki K; Shinohara T; Teshima Y; Yufu K; Takahashi N
    J Cardiol; 2018 Mar; 71(3):310-319. PubMed ID: 28993090
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Chitosan coated furosemide liposomes for improved bioavailability.
    Vural I; Sarisozen C; Olmez SS
    J Biomed Nanotechnol; 2011 Jun; 7(3):426-30. PubMed ID: 21830483
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bioadhesive Chitosan-Coated Cationic Nanoliposomes With Improved Insulin Encapsulation and Prolonged Oral Hypoglycemic Effect in Diabetic Mice.
    Shalaby TI; El-Refaie WM
    J Pharm Sci; 2018 Aug; 107(8):2136-2143. PubMed ID: 29689252
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Liposomes coated with N-trimethyl chitosan to improve the absorption of harmine in vivo and in vitro.
    Chen WL; Yuan ZQ; Liu Y; Yang SD; Zhang CG; Li JZ; Zhu WJ; Li F; Zhou XF; Lin YM; Zhang XN
    Int J Nanomedicine; 2016; 11():325-36. PubMed ID: 26855571
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Vilazodone-phospholipid mixed micelles for enhancing oral bioavailability and reducing pharmacokinetic variability between fed and fasted states.
    El Said HS; Lalatsa A; Al-Mahallawi AM; Saddar El Leithy E; Ghorab DM
    Int J Pharm; 2022 Sep; 625():122080. PubMed ID: 35932929
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Alginate coated chitosan core shell nanoparticles for oral delivery of enoxaparin: in vitro and in vivo assessment.
    Bagre AP; Jain K; Jain NK
    Int J Pharm; 2013 Nov; 456(1):31-40. PubMed ID: 23994363
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mucopenetrating nanoparticles for enhancement of oral bioavailability of furosemide: In vitro and in vivo evaluation/sub-acute toxicity study.
    Radwan SE; Sokar MS; Abdelmonsif DA; El-Kamel AH
    Int J Pharm; 2017 Jun; 526(1-2):366-379. PubMed ID: 28487189
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Development of chitosan-coated liposomes for sustained delivery of tamarind fruit pulp's extract to the skin.
    Phetdee M; Polnok A; Viyoch J
    Int J Cosmet Sci; 2008 Aug; 30(4):285-95. PubMed ID: 18713075
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Preparation and Characterization of Mucoadhesive Loratadine Nanoliposomes for Intranasal Administration.
    Tamaddon L; Mohamadi N; Bavarsad N
    Turk J Pharm Sci; 2021 Sep; 18(4):492-497. PubMed ID: 34496556
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Liposomes coated with thiolated chitosan enhance oral peptide delivery to rats.
    Gradauer K; Barthelmes J; Vonach C; Almer G; Mangge H; Teubl B; Roblegg E; Dünnhaupt S; Fröhlich E; Bernkop-Schnürch A; Prassl R
    J Control Release; 2013 Dec; 172(3):872-8. PubMed ID: 24140721
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Chitosan coated vancomycin hydrochloride liposomes: Characterizations and evaluation.
    Yang Z; Liu J; Gao J; Chen S; Huang G
    Int J Pharm; 2015 Nov; 495(1):508-515. PubMed ID: 26325316
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Preparation and characterization of chitosan coated puerarin liposomes].
    Wang HG; Zhai GX; Lü QZ; Ling PX
    Zhong Yao Cai; 2007 Jan; 30(1):89-92. PubMed ID: 17539312
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.